Emma Andrus, Assistant Editor

Skin responses to lactic acid sting and capsaicin tests varied, according to researchers.

Celebrating the Skin We're In seeks to advocate for health equity through community outreach and education efforts.

These findings come from one of the largest related studies to date.

Researchers found that lipid profile levels were higher in patients with acne vulgaris compared to otherwise healthy patients.

Furthermore, a survey showed that more than half of providers do not discuss clothing modifications, and half report providing patients with wound care supplies that are covered by insurance.

Using hand washing and alcohol-based hand sanitizer use during the COVID-19 pandemic as a baseline, researchers evaluated the effects of these behaviors on the skin’s microbiome.

Researchers noted that serum levels of malondialdehyde and vitamin C are indicators of the impairment caused by systemic oxidative stress.

In the PERSIST study, improvements were sustained through week 104.

Daphne Chan, PhD, MHEcon, discusses the Pathways program, a partnership between the AAD, Janssen, and Kenvue to mentor young, aspiring dermatology providers.

Keep up with the latest headlines in dermatology from the past week, including Novan, Inc.'s bankruptcy filing, rates of melanoma in European Union countries, and more.

Grant applications are open from now until August 24, 2023, with an anticipated project start/end date of January 2024 through July 2025.

Study results are expected to be presented at international dermatology conferences by the end of the year.

Researchers conducted a systematic review and meta-analysis of probiotic treatment efficacy in children with atopic dermatitis.

Clinicians James Q. Del Rosso, DO; Raj Chovatiya, MD, PhD; and Lisa Swanson, MD, PhD, review the study, “Rapid Pruritus Reduction With Ruxolitinib Cream in Patients With Atopic Dermatitis."

Researchers anticipate that upwards of 10,000 adults with various dermatologic conditions will partake in the study.

Researchers conducted a subgroup analysis of the ALLEGRO phase 2b/3 clinical trial to evaluate the safety and efficacy of the drug in patients aged 12-17.

Adam Friedman, MD, FAAD, and Andrew Alexis, MD, MPH, discuss disparities in atopic dermatitis and the ways these can be addressed with teledermatology.

If approved, hidradenitis suppurativa would be the 4th indication for the drug within the European Union.

Co-founders Jeff DeVico and Patrick DePippo discuss their app, ReachRX, which aspires to transform the dermatology and medical landscape through streamlined access to pharmaceutical information.

The aesthetic medical technology company announced that its hair regrowth system will be used in a second study.

Keep up with the latest headlines in dermatology from the past week, including melanoma prevalence in Black men, local and statewide initiatives for skin cancer screening and prevention, and more.

Real-world data demonstrated marked impacts on the economy on a national and personal level.

IL-17A was antagonized by secukinumab, while several other serum levels were decreased in expression.

Patients with the rare autosomal recessive genodermatosis are prone to extreme photosensitivity and changes in skin pigmentation.

Additional patients will be enrolled in the phase 2a study after a clear biological signal was demonstrated in initial participants.

Researchers sought to challenge the perception of microneedling as disruptive to the skin and disease states.

Researchers conducted a review of treatments for the rare disease in the pediatric population.

Dupilumab self-injection has been available to patients in Japan since May 2019.

Compared to patients without melasma, blue light irradiation caused minimal changes in patients with melasma.

ICYMI, this week we had stories about burn management and treatment in light of the July 4 holiday, pearls from the 2023 World Congress of Dermatology meeting in Singapore, acral lentiginous melanoma in AAPI patients, and more.